{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:14:12Z","timestamp":1715386452903},"reference-count":23,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2023,5,31]]},"DOI":"10.1536\/ihj.22-503","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T22:17:18Z","timestamp":1685485038000},"page":"394-399","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of Multiple Drug Use at Discharge in Patients Hospitalized with Heart Failure"],"prefix":"10.1536","volume":"64","author":[{"given":"Daichi","family":"Maeda","sequence":"first","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"Sakane","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"},{"name":"Department of Cardiology, Hokusetsu General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Akamatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoto","family":"Hourai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tokura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Tanaka-Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Hoshiga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Unlu O, Levitan EB, Reshetnyak E, <i>et al<\/i>. Polypharmacy in older adults hospitalized for heart failure. Circ Heart Fail 2020; 13: e006977.","DOI":"10.1161\/CIRCHEARTFAILURE.120.006977"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Murphy SP, Ibrahim NE, Januzzi JL Jr. Heart failure with reduced ejection fraction: a review. JAMA 2020; 324: 488-504.","DOI":"10.1001\/jama.2020.10262"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nobili A, Licata G, Salerno F, <i>et al<\/i>. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 2011; 67: 507-19.","DOI":"10.1007\/s00228-010-0977-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev 2022; 27: 465-92.","DOI":"10.1007\/s10741-021-10135-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Knafl GJ, Riegel B. What puts heart failure patients at risk for poor medication adherence? Patient Prefer Adherence 2014; 8: 1007-18.","DOI":"10.2147\/PPA.S64593"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Scalvini S, Bernocchi P, Villa S, Paganoni AM, La Rovere MT, Frigerio M. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: a population-based retrospective study on 100785 patients. Int J Cardiol 2021; 330: 106-11.","DOI":"10.1016\/j.ijcard.2021.02.016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 2014; 9: 2079-86.","DOI":"10.2147\/CIA.S71178"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wu Y, Zhu W, He X, <i>et al<\/i>. Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial. Br J Gen Pract 2021; 71: e62-70.","DOI":"10.3399\/bjgp21X714245"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-6.","DOI":"10.1056\/NEJM197112232852601"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Suzuki S, Yoshihisa A, Sato Y, <i>et al<\/i>. Clinical significance of get with the guidelines-heart failure risk score in patients with chronic heart failure after hospitalization. J Am Heart Assoc 2018; 7: e008316.","DOI":"10.1161\/JAHA.117.008316"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sairaku A, Morishima N, Amioka M, Maeda J, Watanabe Y, Nakano Y. Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era. J Cardiol 2021; 78: 382-7.","DOI":"10.1016\/j.jjcc.2021.06.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamamoto K, Natsuaki M, Morimoto T, <i>et al<\/i>. Effect of polypharmacy on long-term mortality after percutaneous coronary intervention. Am J Cardiol 2021; 159: 19-29.","DOI":"10.1016\/j.amjcard.2021.08.013"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Millenaar D, Schumacher H, Brueckmann M, <i>et al<\/i>. Cardiovascular outcomes according to polypharmacy and drug adherence in patients with atrial fibrillation on long-term anticoagulation (from the RE-LY Trial). Am J Cardiol 2021; 149: 27-35.","DOI":"10.1016\/j.amjcard.2021.03.024"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sunaga T, Yokoyama A, Nakamura S, <i>et al<\/i>. Association of potentially inappropriate medications with all-cause mortality in the elderly acute decompensated heart failure patients: importance of nonsteroidal anti-inflammatory drug prescription. Cardiol Res 2020; 11: 239-46.","DOI":"10.14740\/cr1078"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ozasa N, Kato T, Morimoto T, <i>et al<\/i>. Polypharmacy and clinical outcomes in hospitalized patients with acute decompensated heart failure. J Cardiovasc Nurs 2023; 38: 33-4.","DOI":"10.1097\/JCN.0000000000000885"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wu JR, Frazier SK, Rayens MK, Lennie TA, Chung ML, Moser DK. Medication adherence, social support, and event-free survival in patients with heart failure. Health Psychol 2013; 32: 637-46.","DOI":"10.1037\/a0028527"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Liao PJ, Mao CT, Chen TL, Deng ST, Hsu KH. Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case-control study. BMJ Open 2019; 9: e026771.","DOI":"10.1136\/bmjopen-2018-026771"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Queneau P, Bannwarth B, Carpentier F, <i>et al<\/i>. Emergency department visits caused by adverse drug events: results of a French survey. Drug Saf 2007; 30: 81-8.","DOI":"10.2165\/00002018-200730010-00008"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pirmohamed M, James S, Meakin S, <i>et al<\/i>. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-9.","DOI":"10.1136\/bmj.329.7456.15"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wawruch M, Zikavska M, Wsolova L, <i>et al<\/i>. Adverse drug reactions related to hospital admission in Slovak elderly patients. Arch Gerontol Geriatr 2009; 48: 186-90.","DOI":"10.1016\/j.archger.2008.01.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf 2006; 29: 79-90.","DOI":"10.2165\/00002018-200629010-00006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP\/START (Screening Tool of Older Persons&apos; potentially inappropriate Prescriptions\/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther 2016; 41: 158-69.","DOI":"10.1111\/jcpt.12372"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rahman MM, Keeton AN, Conner AC, Qian J, Bulloch MN. Comparisons of potentially inappropriate medications and outcomes in older adults admitted to intensive care unit: a retrospective cohort study. J Am Pharm Assoc (2003) 2019; 59: 678-85.","DOI":"10.1016\/j.japh.2019.05.024"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/3\/64_22-503\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:07:02Z","timestamp":1715317622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/3\/64_22-503\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.22-503","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"article-number":"22-503"}}